Nathan Moore, DO.
Nathan Moore, DO
- American Board of Orthopedic Surgery
- Exercise Physiology Program, Brigham Young University
- Doctor of Osteopathy, Touro University, San Francisco
- Residency in Orthopedic Surgery, Ohio University Grandview
- Fellowship in Joint Replacement, The Core Institute, Phoenix, AZ.
Dr. Nathan Moore is an orthopedic surgeon specializing in adult reconstructive joint replacement surgery at Phoenix Spine and Joint Goodyear. Dr. Moore is recognized as a leader in minimally invasive robotic assisted hip and knee replacement surgery.
Dr. Moore’s training began at Brigham Young University where he studied exercise physiology. He received his Doctor of Osteopathy degree from Touro University in the San Francisco Bay Area. He completed residency training in Orthopedic Surgery at the Ohio University Grandview and his fellowship in joint replacement at the Core Institute in Phoenix, AZ.
Dr. Nathan Moore, DO specializes in robotic assisted joint replacement surgeries. Robotic assistance ensures you get the perfect size and fit of your new hip or knee joint.
For total knee replacement Dr. Moore performs a minimally invasive, quadriceps muscle sparing approach to knee replacement surgery. Muscle sparing results in dramatically less pain and faster recovery after surgery. Less pain means less pain medicine. When the knee disease is isolated to a single compartment Dr. Moore performs partial knee replacement as well.
Dr. Moore uses the minimally invasive anterior approach for total hip replacement surgery. Whereas many surgeons are still on the learning curve for this procedure Dr. Moore is an expert, having performed it more than 1,000 times.
Knee pain; knee arthritis; hip pain; hip arthritis; avascular necrosis; congenital anomalies
Minimally invasive robotic assisted TOTAL knee replacement
Minimally invasive robotic assisted PARTIAL knee replacement
Anterior robotic assisted total hip replacement
Gluteus medius (minimus) repair
I, Surgical Robot
Robotic-assisted orthopedic surgical technologies begin a promising resurgence following a year of stunted growth.
According to Persistence Market Research, the orthopedic robotics surgical market reached a valuation of about $1 billion in 2018. The firm predicts that market will expand to account for over $4.1 billion by the end of 2029. Increasing emphasis on value-based outcomes and reduced cost of hospital stays continue to propel the market. The desire to automate also exists for both medical manufacturing and clinical applications. Orthopedic surgical robots fulfill this need while performing surgery.